- Home
- EXEL vs ELS Comparison
EXEL vs ELS Comparison
Compare EXEL & ELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | ELS |
|---|---|---|
| Founded | 1994 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 11.7B |
| IPO Year | 2000 | 1993 |
Fundamental Metrics
Financial Performance| Metric | EXEL | ELS |
|---|---|---|
| Price | $43.87 | $67.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 9 |
| Target Price | $46.60 | ★ $70.39 |
| AVG Volume (30 Days) | ★ 2.7M | 2.0M |
| Earning Date | 02-10-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 3.23% |
| EPS Growth | ★ 57.95 | 2.67 |
| EPS | ★ 2.78 | 2.01 |
| Revenue | ★ $2,320,126,000.00 | $1,537,902,000.00 |
| Revenue This Year | $14.86 | $4.10 |
| Revenue Next Year | $14.93 | $4.31 |
| P/E Ratio | ★ $15.36 | $33.44 |
| Revenue Growth | ★ 6.98 | 0.36 |
| 52 Week Low | $32.38 | $58.15 |
| 52 Week High | $49.62 | $70.35 |
Technical Indicators
Market Signals| Indicator | EXEL | ELS |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 70.13 |
| Support Level | $40.92 | $65.11 |
| Resistance Level | $44.28 | $68.28 |
| Average True Range (ATR) | 1.48 | 1.27 |
| MACD | 0.03 | 0.30 |
| Stochastic Oscillator | 70.53 | 85.91 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the US with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.